14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $3.81 $4.85 Wednesday, 1st May 2024 NVAX stock ended at $4.67. This is 7.85% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 11.89% from a day low at $4.29 to a day high of $4.80.
90 days $3.53 $6.05
52 weeks $3.53 $11.36

Historical Novavax Inc prices

Date Open High Low Close Volume
Jun 08, 2023 $7.66 $7.90 $7.30 $7.69 5 454 432
Jun 07, 2023 $7.23 $7.79 $7.09 $7.67 5 764 228
Jun 06, 2023 $7.72 $7.79 $7.11 $7.23 7 978 173
Jun 05, 2023 $7.81 $8.20 $7.66 $7.85 5 289 218
Jun 02, 2023 $7.87 $7.92 $7.50 $7.62 3 471 115
Jun 01, 2023 $7.99 $8.19 $7.56 $7.72 3 574 885
May 31, 2023 $7.43 $8.13 $7.40 $8.05 7 009 629
May 30, 2023 $7.21 $7.51 $7.09 $7.43 3 776 475
May 26, 2023 $7.14 $7.27 $6.80 $7.21 4 096 229
May 25, 2023 $7.21 $7.35 $6.64 $6.89 6 354 489
May 24, 2023 $8.30 $8.30 $7.24 $7.29 5 527 986
May 23, 2023 $7.56 $8.26 $7.42 $7.99 6 907 704
May 22, 2023 $7.11 $7.61 $7.09 $7.54 3 690 084
May 19, 2023 $7.37 $7.41 $7.10 $7.15 3 715 128
May 18, 2023 $7.75 $7.76 $7.33 $7.42 4 559 566
May 17, 2023 $7.69 $7.80 $7.43 $7.75 3 571 513
May 16, 2023 $8.10 $8.09 $7.58 $7.64 4 231 607
May 15, 2023 $8.40 $8.51 $8.04 $8.11 4 076 187
May 12, 2023 $9.02 $9.34 $8.38 $8.45 4 522 120
May 11, 2023 $9.00 $9.37 $8.60 $8.89 5 454 125
May 10, 2023 $10.01 $10.02 $8.89 $8.99 9 292 479
May 09, 2023 $8.97 $11.36 $8.91 $9.52 42 863 484
May 08, 2023 $7.67 $7.74 $7.27 $7.45 3 491 926
May 05, 2023 $7.62 $8.10 $7.54 $7.71 5 839 497
May 04, 2023 $7.20 $7.62 $7.05 $7.57 3 508 596
Click to get the best stock tips daily for free!

About Novavax Inc

Novavax Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical tria... NVAX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT